Projects funded by the NCN

Physicochemical characterization of cyclodextrins tailored for pH-dependent targeted therapy with anthracycline drugs

Call: OPUS 7 , Panel: ST5

Principal investigator: prof. Renata Bilewicz

Uniwersytet Warszawski, Wydział Chemii

Combined targeted therapy with the use of PPAR receptor ligands or statins and cytostatics aimed at molecular mechanisms...

Call: SONATA 1 , Panel: NZ4

Principal investigator: dr Wojciech Stanisław Placha

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

New drug carriers in targeted anticancer therapy

Call: OPUS 1 , Panel: ST5

Principal investigator: prof. Artur Piotr Terzyk

Uniwersytet Mikołaja Kopernika, Wydział Chemii

BCL11b - Potential Therapeutic Target in T cell Neoplasms

Call: OPUS 5 , Panel: NZ1

Principal investigator: dr hab. Grzegorz Przybylski

Instytut Genetyki Człowieka PAN

The role of poly(ADP-ribose) polymerase and sirtuins in molecular mechanism of cell death. Identification of novel targe...

Call: OPUS 5 , Panel: NZ3

Principal investigator: prof. Joanna Benigna Strosznajder

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Multitasking polymeric lattices included selected DNA oligonucleotide sequences - synthesis, modifications and physioche...

Call: SONATA 3 , Panel: ST5

Principal investigator: dr Ewelina Zabost

Uniwersytet Warszawski, Wydział Chemii

Pathogenesis of ovarian cancer survival in non-adhesion conditions: transcriptomic assessment and studies of molecular t...

Call: PRELUDIUM 2 , Panel: NZ1

Principal investigator: dr Anna Stachurska

Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie

Application of bioconjugation strategy to the synthesis of anticancer Trojan horses

Call: OPUS 28 , Panel: ST5

Principal investigator: dr hab. Michał Piotr Antoszczak

Uniwersytet im. Adama Mickiewicza w Poznaniu

Quad-TNT: Quadruplex-Targeted Photo-Therapy for Triple-Negative Tumors

Call: SONATA BIS 14 , Panel: NZ5

Principal investigator: dr Marco Deiana

Politechnika Wrocławska

Radiolabelled up-converting nanoparticles as theranostic agents for multimodal imaging and targeted therapy

Call: SONATINA 8 , Panel: ST5

Principal investigator: dr Karolina Kinga Zajdel

Narodowe Centrum Badań Jądrowych

Molecular insights into hypoxic tumors – for development of targeted cancer therapeutics

Call: POLONEZ BIS 3 , Panel: NZ5

Principal investigator: dr Marco Deiana

Politechnika Wrocławska

Modifiers of Muscleblind-like genes expression in health and disease.

Call: SONATA BIS 12 , Panel: NZ5

Principal investigator: dr hab. Ewa Agnieszka Stępniak-Konieczna

Uniwersytet Przyrodniczy w Poznaniu, Wydział Rolnictwa, Ogrodnictwa i Biotechnologii

Synthesis of new phthalocyanines for targeted photodynamic cancer therapy.

Call: SONATA 2 , Panel: ST5

Principal investigator: dr Łukasz Andrzej Łapok

Uniwersytet Jagielloński, Wydział Chemii; Zespół Nanotechnologii Polimerów i Biomateriałów

Bioconjugates of 103Pd nanostructures for targeted Auger electron therapy.

Call: OPUS 23 , Panel: ST5

Principal investigator: dr hab. Agnieszka Majkowska-Pilip

Instytut Chemii i Techniki Jądrowej

Searching for new therapeutic targets in polyglutamine diseases

Call: OPUS 22 , Panel: NZ2

Principal investigator: prof. Marta Olejniczak

Instytut Chemii Bioorganicznej PAN

FGFR2-->JunB axis in progression of ER+ breast cancer - molecular analyses and prognostication

Call: PRELUDIUM BIS 3 , Panel: NZ3

Principal investigator: dr hab. Rafał Sebastian Sądej

Gdański Uniwersytet Medyczny, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

Bioconjugates of gold nanoparticles coated by 197/197mHg for Auger electron targeted therapy

Call: PRELUDIUM 20 , Panel: ST5

Principal investigator: Emilia Teresa Majka

Instytut Chemii i Techniki Jądrowej

In search for molecular targets to overcome doxorubicin resistance in triple-negative breast cancer with the use of inno...

Call: PRELUDIUM 20 , Panel: NZ7

Principal investigator: Anna Karolina Pogorzelska

Narodowy Instytut Leków

Molecular and cellular landscape of pulmonary and hepatic metastases of colorectal cancer with potential clinical implic...

Call: PRELUDIUM 20 , Panel: NZ4

Principal investigator: dr Marta Aleksandra Popęda

Gdański Uniwersytet Medyczny, Wydział Lekarski

Physical exercise as a natural mechanism inducing neuroregeneration. Search for the new protein markers and therapeutic ...

Call: OPUS 18 , Panel: NZ7

Principal investigator: dr hab. Katarzyna Zofia Kuter-Nowak

Instytut Farmakologii PAN

Identification and targeting molecular drug resistance mechanisms in adult B-cell acute lymphoblastic leukemia

Call: OPUS 1 , Panel: NZ4

Principal investigator: dr hab. Przemysław Juszczyński

Instytut Hematologii i Transfuzjologii

Hyphenated separation techniques in the study of the molecular mechanisms of metabolic biotransformation of drugs for ta...

Call: SONATA 12 , Panel: ST4

Principal investigator: dr Małgorzata Szultka-Młyńska

Uniwersytet Mikołaja Kopernika, Wydział Chemii

INNOvative antiSEPTic agents for a therapy with a broad spectrum of action

Call: OPUS 10 , Panel: NZ7

Principal investigator: dr Sebastian Kraszewski

Politechnika Wrocławska

Discovery and development of small-molecule inhibitors of USP2 for targeted, non-genotoxic therapy of cancer

Call: OPUS 1 , Panel: ST5

Principal investigator: prof. Tadeusz Andrzej Holak

Uniwersytet Jagielloński, Wydział Chemii

Developing of a new system for targeted anticancer therapy based on betulin derivetive and self-organizing polymeric nan...

Call: HARMONIA 7 , Panel: ST5

Principal investigator: prof. Janusz Edward Kasperczyk

Śląski Uniwersytet Medyczny w Katowicach, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej w Sosnowcu